Christian Ingvar
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 170 publications
Heterogeneous Distribution and Absorbed Dose of Radiolabeled Nanoparticles and Colloids in Sentinel Lymph Nodes.
Journal: Cancer biotherapy & radiopharmaceuticals
Published: February 25, 2025
Physical examinations and whole-body imaging versus physical examinations alone during follow-up after radical surgery of stage IIB-C and III cutaneous malignant melanoma (TRIM): an interim analysis of a multicentre, randomised, phase 3 trial in Sweden.
Journal: The Lancet. Oncology
Published: February 11, 2025
Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.
Journal: Cancers
Published: January 24, 2025
Cohort profile: The Obesity and Disease Development Sweden (ODDS) study, a pooled cohort.
Journal: BMJ open
Published: July 16, 2024
BioMEL: a translational research biobank of melanocytic lesions and melanoma.
Journal: BMJ open
Published: February 03, 2024
Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node Status.
Journal: JAMA surgery
Published: January 10, 2024
Molecular patterns of resistance to immune checkpoint blockade in melanoma.
Journal: Nature communications
Published: July 27, 2023
Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study.
Journal: EClinicalMedicine
Published: May 16, 2023
Can active sun exposure decrease the risk of giant cell arteritis and polymyalgia rheumatica in women?
Journal: Rheumatology advances in practice
Published: May 04, 2023
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.
Journal: Breast cancer research : BCR
Published: April 05, 2023
Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma.
Journal: Annals of surgical oncology
Published: February 27, 2023
Population-based prognostic instrument (SweMR 2.0) for melanoma-specific survival - An ideal tool for individualised treatment decisions for Swedish patients.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: February 10, 2023
Last Updated: 09/26/2026